APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase

被引:11
作者
Adolph, Madison B. [1 ,2 ]
Ara, Anjuman [1 ,3 ,4 ]
Chelico, Linda [1 ]
机构
[1] Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada
[2] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA
[3] Univ Saskatchewan, Coll Med, Saskatchewan Canc Agcy, Saskatoon, SK S7N 5E5, Canada
[4] Univ Saskatchewan, Coll Med, Div Oncol, Saskatoon, SK S7N 5E5, Canada
基金
加拿大健康研究院;
关键词
enzyme-DNA interactions; DNA synthesis; proviral DNA integration; retroviral recombination; polymerase; ANTIVIRAL PROTEIN APOBEC3G; CYTIDINE DEAMINASE; STRAND TRANSFER; SINGLE-CYCLE; IN-VIVO; RECOMBINATION; HYPERMUTATION; REPLICATION; MECHANISM; OLIGOMERIZATION;
D O I
10.1016/j.jmb.2019.02.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The APOBEC3 family of deoxycytidine deaminases has the ability to restrict HIV-1 through deamination-dependent and deamination-independent mechanisms. Although the generation of mutations through deamination of cytosine to uracil in single-stranded HIV-1 (-) DNA is the dominant mechanism of restriction, the deaminase-independent mechanism additionally contributes. Previous observations indicate that APOBEC3 enzymes competitively bind the RNA template or reverse transcriptase (RT) and act as a roadblock to DNA polymerization. Here we studied how the deamination-independent inhibition of HIV-1 RT by APOBEC3C S1881, APOBEC3F, APOBEC3G, and APOBEC3H affected RT template switching. We found that APOBEC3F could promote template switching of RT, and this was dependent on the high affinity with which it bound nucleic acids, suggesting than an APOBEC3 "road-block" can force template switching. Our data demonstrate that the deamination-independent functions of APOBEC3 enzymes extend beyond only disrupting RT DNA polymerization. Since alterations to the RT template switching frequency can result in insertions or deletions, our data support a model in which APOBEC3 enzymes use multiple mechanisms to increase the probability of generating a mutated and nonfunctional virus in addition to cytosine deamination. (C) 2019 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:1339 / 1352
页数:14
相关论文
共 73 条
[1]   Biochemical Basis of APOBEC3 Deoxycytidine Deaminase Activity on Diverse DNA Substrates [J].
Adolph, Madison B. ;
Love, Robin P. ;
Chelico, Linda .
ACS INFECTIOUS DISEASES, 2018, 4 (03) :224-238
[2]   Cytidine deaminase efficiency of the lentiviral viral restriction factor APOBEC3C correlates with dimerization [J].
Adolph, Madison B. ;
Ara, Anjuman ;
Feng, Yuqing ;
Wittkopp, Cristina J. ;
Emerman, Michael ;
Fraser, James S. ;
Chelico, Linda .
NUCLEIC ACIDS RESEARCH, 2017, 45 (06) :3378-3394
[3]   Retroviral Restriction Factor APOBEC3G Delays the Initiation of DNA Synthesis by HIV-1 Reverse Transcriptase [J].
Adolph, Madison B. ;
Webb, Jonathon ;
Chelico, Linda .
PLOS ONE, 2013, 8 (05)
[4]   Natural APOBEC3C variants can elicit differential HIV-1 restriction activity [J].
Anderson, Brett D. ;
Ikeda, Terumasa ;
Moghadasi, Seyed Arad ;
St Martin, Amber ;
Brown, William L. ;
Harris, Reuben S. .
RETROVIROLOGY, 2018, 15
[5]   Correlated template-switching events during minus-strand DNA synthesis: a mechanism for high negative interference during retroviral recombination [J].
Anderson, JA ;
Teufel, RJ ;
Yin, PD ;
Hu, WS .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1186-1194
[6]   Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G [J].
Ara, Anjuman ;
Love, Robin P. ;
Follack, Tyson B. ;
Ahmed, Khawaja A. ;
Adolph, Madison B. ;
Chelico, Linda .
JOURNAL OF VIROLOGY, 2017, 91 (03)
[7]   Different Mutagenic Potential of HIV-1 Restriction Factors APOBEC3G and APOBEC3F Is Determined by Distinct Single-Stranded DNA Scanning Mechanisms [J].
Ara, Anjuman ;
Love, Robin P. ;
Chelico, Linda .
PLOS PATHOGENS, 2014, 10 (03)
[8]  
ARTS EJ, 1994, J BIOL CHEM, V269, P14672
[9]   PREFERENTIAL INCORPORATION OF NUCLEOSIDE ANALOGS AFTER TEMPLATE SWITCHING DURING HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE TRANSCRIPTION [J].
ARTS, EJ ;
WAINBERG, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) :1008-1016
[10]  
Arts Eric J., 1995, Journal of Biomedical Science, V2, P314, DOI 10.1007/BF02255218